• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA EXCHANGE SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA EXCHANGE SET Back to Search Results
Catalog Number 000000000000010220
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Bradycardia (1751); Cardiac Arrest (1762); Death (1802)
Event Date 01/31/2015
Event Type  Death  
Event Description
The customer reported that the patient was undergoing a therapeutic plasma exchange (tpe) procedure and she went into cardiac arrest that lead to her expiration.Approximately 3 hours into the procedure, her heart rate decreased.The physician was notified and a code was called.The code team performed standard procedure for cardiac arrest, but was unable to revive the patient.Per the customer, the cause of death was related to the patient's disease progression and they did not allege a deficiency with the system or disposable.The customer declined to provide patient identifier, age and weight.Patient weight and gender were obtained from the run data file.The disposable set is not available for return because it was discarded by the customer.
 
Manufacturer Narrative
(b)(4) manufacturing review and sterilization process review investigation: fluids used during the procedure were anticoagulant (acda), saline (b)(4) and fresh frozen plasma (ffp) was used for replacement fluid.The customer stated that the patient had ttp, suffered labored breathing, and had low oxygen saturation levels before the procedure began.Functional checkout of the machine was performed by a terumo bct service technician.All functional tests met specifications.A saline run with all alarm tests was performed without failure.All tests passed.The run data file (rdf) was analyzed for this event.The signals in the rdf indicated that the system operated as intended.According to a published article in the american journal of emergency medicine, cardiac arrest can be linked to ttp disorder.Because ttp is a disease characterized by thrombi in micro circulation throughout the body, the flow of blood to the lungs can become limited or blocked.When this occurs, it is referred to as pulmonary embolism.Fulminant pe shows a high prevalence and often degenerates into cardiopulmonary arrest.Spectra optia apheresis essentials guide provides the following cautions: "the physiological condition of patients may affect the outcomes of procedures performed on the spectra optia system." a review of the device history record (dhr) for this unit showed no irregularities during manufacturing that were relevant to this issue.The patient¿s official release record and/or autopsy report were requested from the hospital¿s medical records department.Information, such as name, dob, and ssn, was stated as necessary to obtain those records.Previous attempts to obtain the patient id were unsuccessful and therefore, the official medical report(s) could not be obtained.Root cause: the definitive cause for the patient¿s death is undetermined but is not alleged to be due to the spectra optia system.Based on the nurse's description of events, dlog analysis,and machine service inspection, the likely root cause was the patient's disease state, but this could not be confirmed by the physician or with medical records.
 
Manufacturer Narrative
This record was identified during a retrospective review of mdrs to identify records in which an event occurred, but the type of reportable event was not indicated appropriately in the mdr form.This supplement is being filed to modify information to align with the reported event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA
Type of Device
SPECTRA OPTIA EXCHANGE SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer Contact
glenda o'neill
10811 w. collins ave
lakewood, CO 80215
3032314051
MDR Report Key4554905
MDR Text Key5525983
Report Number1722028-2015-00063
Device Sequence Number1
Product Code LKN
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
BK140151
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,health professional
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 02/02/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/27/2015
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/01/2016
Device Catalogue Number000000000000010220
Device Lot Number10W3228
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/03/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/29/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Weight73
-
-